Literature DB >> 30001984

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment.

Mary-Kate Malecek1, Mark Fiala1, Mark Schroeder1, James Dukeman1, Armin Ghobadi1, Keith Stockerl-Goldstein1, Tanya Wildes1, Ravi Vij2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30001984     DOI： 10.1016/j.clml.2018.06.008

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

Review 1.  Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.

Authors:  Tanya M Wildes; Kenneth C Anderson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma.

Authors:  Mark A Fiala; Nicole C Foley; Sonja Zweegman; Ravi Vij; Tanya M Wildes
Journal:  J Geriatr Oncol       Date:  2020-03-10       Impact factor: 3.599

Review 3.  Management of Newly Diagnosed Elderly Multiple Myeloma Patients.

Authors:  Crystal Antoine-Pepeljugoski; Marc Justin Braunstein
Journal:  Curr Oncol Rep       Date:  2019-05-24       Impact factor: 5.075
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.